Citadel Advisors’s ENDRA Life Sciences NDRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-21
| Closed | -$52.1K | – | 6276 |
|
|
2023
Q2 | $52.1K | Buy |
+21
| New | +$52.1K | ﹤0.01% | 4981 |
|
|
2022
Q4 | – | Sell |
-2
| Closed | -$23K | – | 6485 |
|
|
2022
Q3 | $23K | Buy |
+2
| New | +$23K | ﹤0.01% | 5508 |
|
|
2022
Q1 | – | Sell |
-1
| Closed | -$34K | – | 6849 |
|
|
2021
Q4 | $34K | Buy |
+1
| New | +$34K | ﹤0.01% | 6239 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6256 |
|
|
2021
Q2 | – | Sell |
-1
| Closed | -$130K | – | 6835 |
|
|
2021
Q1 | $130K | Buy |
+1
| New | +$130K | ﹤0.01% | 5689 |
|
|
2020
Q4 | – | Sell |
-1
| Closed | -$33K | – | 5393 |
|
|
2020
Q3 | $33K | Hold |
1
| – | – | ﹤0.01% | 4462 |
|
|
2020
Q2 | $36K | Buy |
+1
| New | +$36K | ﹤0.01% | 4427 |
|
|
2019
Q2 | – | Sell |
-1
| Closed | -$29K | – | 4940 |
|
|
2019
Q1 | $29K | Buy |
+1
| New | +$29K | ﹤0.01% | 4358 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 4257 |
|